Related Experiment Videos
[Percutaneous nephrostomy in malignant ureteral obstruction]
1Urologische Klinik, Leopoldina-Krankenhaus der Stadt Schweinfurt.
Deutsche Medizinische Wochenschrift (1946)
|December 6, 1996
Summary
Percutaneous nephrostomy (PN) for malignant tumors offers limited survival benefits and often involves significant hospitalization. Pre-procedure patient and family counseling is crucial regarding realistic outcomes.
Area of Science:
- Urology
- Oncology
- Nephrology
Background:
- Postrenal anuria due to malignant tumors presents significant challenges.
- Percutaneous nephrostomy (PN) is a procedure to manage urinary obstruction.
Purpose of the Study:
- To evaluate survival duration and quality of life in patients undergoing PN for malignant tumors causing postrenal anuria.
Main Methods:
- Retrospective analysis of 50 patients with malignancy-induced postrenal anuria who underwent ultrasound-guided PN.
- Data collected on survival time, quality of life, and disease progression from PN to death.
Main Results:
- Survival post-PN ranged from 4 days to 16 months (average 4.3 months).
- 52% of patients died within 3 months, and 82% within 6 months.
- Patients spent an average of 44.5% of their remaining life hospitalized, with frequent complications and pain.
Conclusions:
- Prolonged survival from PN may not align with patient expectations.
- Comprehensive pre-procedure information and counseling for patients and families are essential.